Shares of PTC Inc. PTC inched 0.24% higher to $187.58 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.09% to 5,930.85 ...

NTPC too has a separate power trading arm, NTPC Vidyut Vyapar Nigam Ltd. Both PTC India and its subsidiary PFS have been in ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on PTCT: PTC Therapeutics ...

Analyst Joseph Schwartz from Leerink Partners reiterated a Hold rating on PTC Therapeutics (PTCT – Research Report) and increased the price target to $50.00 from $40.00. Don't Miss our Black ...

PTC (Nasdaq: PTC), a global software company that enables manufacturers and product companies to digitally transform how they engineer, manufacture, and service the physical products that the ...

More than two years after its approval in Europe, PTC Therapeutics' gene therapy for rare genetic disorder AADC deficiency will soon be made available to patients in the US. The FDA has approved ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew B. Klein, M.D., Chief Executive Officer of PTC, will discuss these updates at ...

Neil Barua, who took the wheel of Seaport-based PTC Inc. (Nasdaq: PTC) last February, earned $16.4 million in total compensation in 2024, according to the company's federal securities filings ...